3 Russell 2000 Stocks We Steer Clear Of
PLEASANTON, Calif. , July 15, 2026 /PRNewswire/ --Â 10x Genomics, Inc. Â (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced...
3 Cash-Heavy Stocks We Find Risky
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)
1 Unprofitable Stock on Our Watchlist and 2 We Brush Off
Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platforms
3 Small-Cap Stocks with Questionable Fundamentals
Acquisition Expands 10x Genomics' Capabilities in Proteomics